Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    16192448 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Pharmacokinetics of Inhaled Monodisperse Fluticasone Propionate
Conditions: Healthy;   Asthma
Intervention: Drug: Fluticasone Propionate
2 Unknown  The Clinical Effect of Monodisperse Fluticasone Propionate in Asthma
Condition: Asthma
Interventions: Drug: Fluticasone Propionate  50 micrograms;   Drug: Inhaled, Metered dose inhaler, 250 micrograms dose (total dose);   Drug: Placebo monodisperse aerosol dose
3 Completed IPF Drug Deposition Study
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Salbutamol
4 Recruiting Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: SALBUTAMOL

Indicates status has not been verified in more than two years